Withdrawal was atypical and painful. He’s moved back home, will not be able to work professionally until treatment starts again someday.
I’ve had to dig into the larger process in an attempt to understand. There is weak to no evidence that drug screening ADHD patients impacts amphetamine misuse (meth, whole separate unrelated area.) Similarly urine testing for the pharmacokinetics of ADHD meds to optimize dosing — sadly, truly not a thing. I keep getting the feeling that this new trend is about reducing costs cloaked in an abuse prevention excuse.